InspireMD appoints Michael Lawless as CFO, succeeding Craig Shore

InspireMD, Inc.

Michael Lawless appointed CFO effective on/before June 30, 2025; succeeds Craig Shore who served ~15 years.
Base salary of $375,000 annually, plus performance bonus up to 50% of base salary.
Inducement grant: 212,000 stock options and 465,000 restricted shares, vesting over 3 years under NASDAQ Rule 5635(c)(4).
Employment agreement has 3-year initial term with automatic renewal; severance includes 6 months base salary (non-CIC) or 12 months (CIC).
Lawless previously CFO of Lifeward (LFWD) and held senior finance roles at Azenta, PerkinElmer, and Momenta Pharmaceuticals.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michael Lawless

Chief Financial Officer

NSPR · InspireMD, Inc.

Effective: 2025-06-30
Filed: June 3, 2025, 7:59 PM ET

On June 2, 2025, InspireMD, Inc. (the “ Company ”) appointed Michael Lawless as Chief Financial Officer of the Company, effective on or before June 30, 2025 (the “ Effective Date ”).

Departed

Craig Shore

Chief Financial Officer

NSPR · InspireMD, Inc.

Effective: 2025-06-30
Successor: Michael Lawless
Filed: June 3, 2025, 7:59 PM ET

On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company’s Chief Financial Officer will be terminated simultaneous with Mr. Lawless’s appointment.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael Lawless was appointed as Chief Financial Officer at InspireMD, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On June 2, 2025, InspireMD, Inc. (the “ Company ”) appointed Michael Lawless as Chief Financial Officer of the Company, effective on or before June 30, 2025 (the “ Effective Date ”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Craig Shore was terminated as Chief Financial Officer at InspireMD, Inc..

Action: terminated
Role: Chief Financial Officer

Exact text from the filing

On the Effective Date, Mr. Lawless will succeed Craig Shore, whose employment as the Company’s Chief Financial Officer will be terminated simultaneous with Mr. Lawless’s appointment.

View on SEC.gov

InspireMD, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-013433

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.